By InvitationPhase 4

Antibiotic Prophylaxis in Pediatric Open Fractures

United States800 participantsStarted 2023-09-11

Plain-language summary

This research will involve a prospective study on infection rates after grade 1 or 2 open fractures in the skeletally immature pediatric population. There will be 3 arms: one dose intravenous cefazolin, 24 hours intravenous cefazolin, and 24 hours intravenous cefazolin plus 5 days of oral cephalexin.

Who can participate

Age range

0 Years – 17 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pediatric patients ages 0-17 years old * Skeletally immature patients, as confirmed by xray imaging evaluated by an orthopaedic surgeon * Patient as sustained a grade 1 or 2 open fracture within 24 hours of presentation * Physician plans to manage the fracture non-operatively Exclusion Criteria: * Patients 18 years or older * Skeletally mature patients, as as confirmed by xray imaging evaluated by an orthopaedic surgeon * Patients with grade 3 open fractures * Gross contamination of the fracture * Fracture requires surgery * Immunocompromised patients * Allergies to cephalosporins * Severe penicillin allergy * non-English speaking patients \&/or guardian

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of participants with an infection at the fracture site.

Timeframe: Up to 3 months following injury.

Trial details

NCT IDNCT06055712

SponsorSt. Louis University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2033-09

View on ClinicalTrials.gov More Fractures, Open trials